# Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology

> **NCT03681574** · PHASE4 · COMPLETED · sponsor: **Hospital Infantil Albert Sabin** · enrollment: 135 (actual)

## Conditions studied

- Pain, Postoperative
- Agitation States as Acute Reaction to Exceptional Stress
- Anesthesia
- Vomiting

## Interventions

- **DRUG:** Placebo Group
- **DRUG:** GABA 15mg/kg Group
- **DRUG:** GABA 30mg/kg Group

## Key facts

- **NCT ID:** NCT03681574
- **Lead sponsor:** Hospital Infantil Albert Sabin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2018-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681574, "Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03681574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*